Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice-Reference-Cited by-同舟云学术

Activin type IIA decoy receptor and intermittent parathyroid hormone in combination overturns the bone loss in disuse-osteopenic mice

Published:2021-01 Issue: Volume:142 Page:115692
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Brent Mikkel Bo,Lodberg Andreas,Bromer Frederik Duch,van der Eerden Bram C.J.,Eijken Marco,Brüel Annemarie,Thomsen Jesper Skovhus

Funder

Aarhus University

A.P. Møller Foundation for the Advancement of Medical Science

Elsass Foundation

Dagmar Marshall's Foundation

Novo Nordisk Foundation

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference76 articles.

1. Neuromuscular dysfunction, independent of gait dysfunction, modulates trabecular bone homeostasis in mice;Bain;J. Musculoskelet. Neuronal Interact.,2019

2. Effects of sciatic neurectomy on the femur in growing rats: application of peripheral quantitative computed tomography and Fourier transform infrared spectroscopy;Yonezu;J. Bone Miner. Metab.,1999

3. Osteoporosis after spinal cord injury;Jiang;Osteoporos. Int.,2006

4. Results from bone mineral density scans in twenty-two complete lesion paraplegics;Wood;Spinal Cord,2001

5. Immobilization induced osteopenia is strain specific in mice;Lodberg;Bone Reports.,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis;Journal of Bone and Mineral Research;2024-07-08

2. Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies;Pharmacology & Therapeutics;2023-04

3. PTH 1-34 promoted bone formation by regulating iron metabolism in unloading-induced bone loss;Frontiers in Endocrinology;2023-02-02

4. Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats;Bone;2022-07

5. Effect of Acetazolamide and Zoledronate on Simulated High Altitude-Induced Bone Loss;Frontiers in Endocrinology;2022-02-09